Cargando…
Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide
We present an extremely rare case report of a 29-year-old multiple myeloma patient with central nervous system involvement and secondary hemophagocytic lymphohistiocytosis (HLH). We observed that HLH was presumably triggered by the immunomodulatory drug—lenalidomide. HLH is frequently misdiagnosed o...
Autores principales: | Milczarek, Sławomir, Kulig, Piotr, Baumert, Bartłomiej, Łanocha, Aleksandra, Sommerfeld, Krzysztof, Borowiecka, Ewa, Osękowska, Bogumiła, Paczkowska, Edyta, Zdziarska, Barbara, Machaliński, Bogusław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606933/ https://www.ncbi.nlm.nih.gov/pubmed/36295511 http://dx.doi.org/10.3390/medicina58101350 |
Ejemplares similares
-
COVID-19 during Early Phase of Autologous Stem Cell Transplantation
por: Milczarek, Sławomir, et al.
Publicado: (2021) -
The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma
por: Łuczkowska, Karolina, et al.
Publicado: (2021) -
Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives
por: Kulig, Piotr, et al.
Publicado: (2023) -
Case of Patient with AML with Complex Karyotype including Ultra-Rare t(4;8)(q32;q13), t(4;11)(q21;p15) and Familial Aggregation of Myeloid Malignancies
por: Milczarek, Sławomir, et al.
Publicado: (2022) -
Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter
por: Milczarek, Sławomir, et al.
Publicado: (2023)